pirarubicin and Medulloblastoma

pirarubicin has been researched along with Medulloblastoma* in 1 studies

Other Studies

1 other study(ies) available for pirarubicin and Medulloblastoma

Article	Year
[A case of recurrent medulloblastoma treated by combination therapy with cisplatinum and tetrahydropyranyladriamycin (PP therapy)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:6 PP therapy, combination therapy with Cis-platinum (CDDP) and tetrahydropyranyladriamycin (THP-ADR), were performed on a case of recurrent medulloblastoma. CDDP and THP-ADR involve agents difficult to pass the blood brain barrier (BBB), but can pass BBB on the metastatic lesion. PP therapy is considered to be one of the most effective agents for the treatment of recurrent malignant brain tumor. Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Humans; Hypothalamic Neoplasms; Male; Medulloblastoma	1991

Article

Year

[A case of recurrent medulloblastoma treated by combination therapy with cisplatinum and tetrahydropyranyladriamycin (PP therapy)].

Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:6

PP therapy, combination therapy with Cis-platinum (CDDP) and tetrahydropyranyladriamycin (THP-ADR), were performed on a case of recurrent medulloblastoma. CDDP and THP-ADR involve agents difficult to pass the blood brain barrier (BBB), but can pass BBB on the metastatic lesion. PP therapy is considered to be one of the most effective agents for the treatment of recurrent malignant brain tumor.

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Humans; Hypothalamic Neoplasms; Male; Medulloblastoma

1991